CPIX.US Cumberland Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
5.88 USD
Close of Nov 14, 2026
1.13 9.28
Market cap
USD 88.2M
P/E
-
P/B
1.36x
ROE
129.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CPIX.US undervalued?

Graham number

The Graham number of Cumberland Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cumberland Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Cumberland Pharmaceuticals Inc yet.

Cumberland Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients rece…

Full company profile